Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Fujifilm to Buy U.S. Vaccine Maker to Expand Biopharma Business

By Pharmaceutical Processing | October 27, 2014

Fujifilm will acquire U.S. vaccine maker Kalon Biotherapeutics to expand its biopharmaceutical business, with the Japanese firm having gained prominence for offering a possible treatment for Ebola patients.

A Fujifilm subsidiary in the United States signed last Wednesday an agreement with the owners of Kalon, including the State of Texas, to acquire 49 percent of the total membership interest in Kalon for several billions of yen by the end of the year, Fujifilm said.

The subsidiary, Fujifilm Diosynth Biotechnologies U.S.A. Inc., will be entitled to appoint a majority of Kalon’s board members. It may later raise its share in Kalon up to 100 percent, depending on achievement of certain stages in the development of their relations, set forth in the agreement.

The acquisition of Kalon, which makes vaccines on a contract basis, will help Fujifilm enter the growing market, the Tokyo-based photo film and business machinery maker said.

A newcomer to the pharmaceutical industry, Fujifilm gained the global spotlight after its anti-influenza drug was used to treat patients infected with the Ebola virus.

The company said last week it will additionally produce the drug Avigan Tablets, or Favipiravir, developed by another subsidiary, in preparation for their administration to a larger number of Ebola patients. The deadly virus has killed thousands in West Africa and infections have also been confirmed in the United States and Europe.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE